Avalyn Pharma Inc. Common Stock (AVLN) — Financial Flexibility Index
Avalyn Pharma Inc. Common Stock (AVLN) has a Financial Flexibility Index of -0.21x as of December 2025. Free cash flow of $-81.14 Million (operating CF $-81.48 Million minus capex $344.00K) represents 0% of total liabilities ($387.54 Million). Check Avalyn Pharma Inc. Common Stock asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Avalyn Pharma Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Avalyn Pharma Inc. Common Stock across 2 annual periods. See AVLN working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Avalyn Pharma Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Avalyn Pharma Inc. Common Stock. For the full company profile including market capitalisation, see AVLN market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.21x | $-81.14 Million | $-81.48 Million | $387.54 Million | ▼ -29.7% |
| 2024 | -0.16x | $-48.27 Million | $-48.37 Million | $299.04 Million | — |